Treatment of Youth With ADHD and Anxiety
Completed · Not applicable
Conditions studied: Attention Deficit Hyperactivity Disorder, Anxiety, Separation, Social Phobia, Generalized Anxiety Disorder
In brief
The purpose of this NIMH-sponsored pilot study is to collect information on the efficacy and safety of drug treatments for children and adolescents who suffer from both ADHD and anxiety disorders. Specifically, the study will examine the benefits of the stimulant medication both alone and in combination with fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) that has antianxiety effects. Young people aged 6 to 17 diagnosed with these co-occurring disorders may be eligible to participate.
Key facts
- Study ID
- NCT00012584
- Run by
- National Institute of Mental Health (NIMH)
- People needed
- 120
- Starts
- 2000-11-01
- Expected to finish
- 2002-05-01
- Last updated by the study team
- 2009-06-24
Who can join
Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA Neuropsychiatric Institute — Los Angeles, California, United States
- Johns Hopkins School of Medicine — Baltimore, Maryland, United States
- New York University Child Study Center — New York, New York, United States
- New York State Psychiatric Institute — New York, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.